Skip to main content
. 2023 Nov 27;7:120. doi: 10.1186/s41687-023-00654-z

Table 1.

Patient demographic and disease characteristics at baseline (patient-reported outcome population analysis set: part B)

Characteristic Adolescents aged 12 to < 18 years
(n = 79)
Adults aged ≥ 18 years
(n = 160)
Overall PRO population analysis sample
(N = 239)
Age (years)
Mean (SD) 15.0 (1.62) 34.7 (11.32) 28.1 (13.14)
Median 15.0 35.0 24.0
Q1: Q3 14.0: 16.0 24.0: 41.5 16.0: 38.0
Min: max 12: 17 18: 68 12: 68
Sex, n (%)
Male 57 (72.2%) 95 (59.4%) 152 (63.6%)
Female 22 (27.8%) 65 (40.6%) 87 (36.4%)
Race, n (%)
White 64 (81.0%) 152 (95.0%) 216 (90.4%)
Black or African American 7 (8.9%) 1 (0.6%) 8 (3.3%)
Asian 2 (2.5%) 3 (1.9%) 5 (2.1%)
Other 6 (7.6%) 1 (0.6%) 7 (2.9%)
Not reported 0 3 (1.9%) 3 (1.3%)
Ethnicity, n (%)
Not Hispanic or Latino 76 (96.2%) 149 (93.1%) 225 (94.1%)
Hispanic or Latino 3 (3.8%) 10 (6.3%) 13 (5.4%)
Unknown 0 1 (0.6%) 1 (0.4%)
Atopic comorbidity, n (%)
Allergic rhinitis 57 (72.2%) 96 (60.0%) 153 (64.0%)
Asthma 33 (41.8%) 29 (18.1%) 107 (44.8%)
Atopic dermatitis 45 (57.0%) 62 (38.8%) 62 (25.9%)

PRO, patient-reported outcome; Q1, quartile 1; Q3, quartile 3; SD, standard deviation